abrdn Income Credit Strategies Fund vs McKesson Corporation — how do they compare? abrdn Income Credit Strategies Fund trades at $5.11 (market cap $641.16M), while McKesson Corporation trades at $895 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 164× abrdn Income Credit Strategies Fund's market cap, and abrdn Income Credit Strategies Fund pays the higher dividend (18.2%). Which is the better fit depends on your goals.
| ACP | MCK | |
|---|---|---|
Market Cap | $641.16M | $105.14B |
Sector | Financials | Health |
52-Week High | $5.98 | $995.69 |
52-Week Low | $5.01 | $659.01 |
Dividend Yield | 18.2% | 0.42% |
Enterprise Value | — | $111.67B |
Trailing returns across standard periods
Latest headlines on both assets
abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.
Read more on ACP →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →